top of page
Executive Spotlights

Boston Scientific Acquires Relievant Medsystems in $850M Deal for Chronic Pain Therapy

Marlborough, MA, September 19, 2023 (Reuters) -- Boston Scientific (BSX.N) announced its acquisition of the innovative medical technology firm, Relievant Medsystems. This tdeal, valued at an upfront cash payment of $850 million, grants Boston Scientific access to a cutting-edge FDA-cleared therapy designed to combat chronic pain.

Read full article here.

Recent Posts

See All

Rahway, NJ & Cambridge, MA, November 21, 2023 (Business Wire) -- Merck (NYSE: MRK), also known as MSD outside of the United States and Canada, and Caraway Therapeutics, Inc. declare a definitive agr

Life Science Headlines
bottom of page